The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer

---

Sendur M. A. N., Ozdemir N., Aksoy S., Yazici O., Yazilitas D., Akinci M. B., ...More

European Cancer Congress, Vienna, Austria, 01 January 2015, vol.51, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 51
• Doi Number: 10.1016/s0959-8049(16)31266-7
• City: Vienna
• Country: Austria
• Hacettepe University Affiliated: Yes